Vitamin Shoppe (VSI) Misses Q3 EPS by 14c

Vitamin Shoppe (NYSE: VSI) reported Q3 EPS of $0.03, $0.14 worse than the analyst estimate of $0.17. Revenue for the quarter came in at $288.2 million versus the consensus estimate of $298.11 million. Management also reported total comp sales down 6.6%-5.8 excluding hurricane impacts.

For earnings history and earnings-related data on Vitamin Shoppe (VSI) click here.

You May Also Be Interested In

• Medtronic (MDT) Tops Q1 EPS by 6c, Beats on Revenue; Offers FY27 EPS Guidance
• Kustom Entertainment agrees to buy Tickets For Less operator TFL
• Why UBS thinks this European chipmaker is still undervalued despite its premium valuation